top of page

Description

 

High temperature thermoplastics are now more frequently used in the medical sector because they can survive sterilisation methods like steam autoclaving and ethylene oxide. Material failure is a main or potential reason for between thirty and forty percent of medical device recalls by the U.S. Food & Drug Administration (FDA), according to a recent report by research and development company Battelle. This is a key factor in the medical industry's preference for high temperature thermoplastics.

High Temperature Thermoplastics Market Trends & Forecast 2020-2030

4.500,00$Preis
  • Table of Contents

    Table of Contents
    1. Executive Summary
    2. Industry Outlook

    2.1. Industry Overview
    2.2. Industry Trends
    3. Market Snapshot
    3.1. Market Definition
    3.2. Market Outlook
    3.2.1. Porter Five Forces
    3.3. Related Markets
    4. Market characteristics
    4.1. Market Overview
    4.2. Market Segmentation
    4.3. Market Dynamics
    4.3.1. Drivers
    4.3.2. Restraints
    4.3.3. Opportunities
    4.4. DRO - Impact Analysis
    5. End-use Industry: Market Size & Analysis
    5.1. Overview
    5.2. Transportation
    5.3. Electrical & Electronics
    5.4. Industrial
    5.5. Medical
    5.6. Others
    6. Temperature range: Market Size & Analysis
    6.1. Overview
    6.2. HTTs (Range 302˚F-449.6˚F)
    6.3. Extreme Temperature Thermoplastics (Range >449.6˚F)
    7. Resign type: Market Size & Analysis
    7.1. Overview
    7.2. High Temperature Fluoropolymers (High Temperature FPs)
    7.3. High Performance Polyamide (HPPA)
    7.4. Polyphenylene Sulfide (PPS)
    7.5. Sulfone Polymers (SP)
    7.6. Liquid Crystal Polymers (LCP)
    7.7. Aromatic Ketone Polymers (AKP)
    7.8. Poly-imide (PI)
    8. Geography: Market Size & Analysis
    8.1. Overview
    8.2. North America (U.S., Mexico, Canada)
    8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
    8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
    8.5. Latin America (Brazil, Argentina)
    8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
    9. Competitive Landscape
    9.1. Competitor Comparison Analysis
    9.2. Market Developments
    9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
    9.2.2. Product Launches and execution
    10. Vendor Profiles
    10.1. BASF SE (Germany)
    10.1.1. Overview
    10.1.2. Financial Overview
    10.1.3. Product Offerings
    10.1.4. Developments
    10.1.5. Business Strategy
    10.2. Celanese Corporation (U.S.)
    10.2.1. Overview
    10.2.2. Financial Overview
    10.2.3. Product Offerings
    10.2.4. Developments
    10.2.5. Business Strategy
    10.3. Solvay (Belgium.)
    10.3.1. Overview
    10.3.2. Financial Overview
    10.3.3. Product Offerings
    10.3.4. Developments
    10.3.5. Business Strategy
    10.4. Arkema (France)
    10.4.1. Overview
    10.4.2. Financial Overview
    10.4.3. Product Offerings
    10.4.4. Developments
    10.4.5. Business Strategy
    10.5. Evonik Industries AG (Germany)
    10.5.1. Overview
    10.5.2. Financial Overview
    10.5.3. Product Offerings
    10.5.4. Developments
    10.5.5. Business Strategy
    10.6. DowDuPont ( U.S.)
    10.6.1. Overview
    10.6.2. Financial Overview
    10.6.3. Product Offerings
    10.6.4. Developments
    10.6.5. Business Strategy
    10.7. SABIC (Saudi Arabia)
    10.7.1. Overview
    10.7.2. Financial Overview
    10.7.3. Product Offerings
    10.7.4. Developments
    10.7.5. Business Strategy
    10.8. Victrex plc (U.K)
    10.8.1. Overview
    10.8.2. Financial Overview
    10.8.3. Product Offerings
    10.8.4. Developments
    10.8.5. Business Strategy
    10.9. Royal DSM  (the Netherlands)
    10.9.1. Overview
    10.9.2. Financial Overview
    10.9.3. Product Offerings
    10.9.4. Developments
    10.9.5. Business Strategy
    10.10. TORAY INDUSTRIES
    10.10.1. Overview
    10.10.2. Financial Overview
    10.10.3. Product Offerings
    10.10.4. Developments
    10.10.5. Business Strategy
    11. Analyst Opinion
    12. Annexure
  • LinkedIn
  • Twitter
  • Twitter
  • Linkedin
bottom of page